[
    [
        {
            "time": "2018-01-22",
            "original_text": "医药生物行业周报：2018年新气象 新医药 看好商业健康险和创新药物的快速发展",
            "features": {
                "keywords": [
                    "医药生物",
                    "商业健康险",
                    "创新药物",
                    "快速发展"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药生物行业周报：2018年新气象 新医药 看好商业健康险和创新药物的快速发展",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-01-22",
            "original_text": "22日可能影响股价重要财经证券资讯速递(更新中)",
            "features": {
                "keywords": [
                    "股价",
                    "财经",
                    "证券资讯"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "22日可能影响股价重要财经证券资讯速递(更新中)",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-01-22",
            "original_text": "医药生物行业周报:看好估值合理的子行业龙头,重点推荐恒瑞医药、长春高新、美年健康等",
            "features": {
                "keywords": [
                    "医药生物",
                    "子行业龙头",
                    "恒瑞医药",
                    "长春高新",
                    "美年健康"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药生物行业周报:看好估值合理的子行业龙头,重点推荐恒瑞医药、长春高新、美年健康等",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        }
    ]
]